Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia
Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as methotrexate and fludarabine, work in
different ways to stop the growth of cancer cells, either by killing the cells or by stopping
them from dividing.
PURPOSE: This phase II trial is studying how well methotrexate works as first-line therapy
and fludarabine works as second-line therapy in treating patients with T-cell large granular
lymphocytic leukemia.